Volume 68 Received 5 October 2012 | ||||||||||
| ||||||||||
aLSPCMIB, UMR-CNRS 5068, Université de Toulouse, 118 route de Narbonne, F-31062 Toulouse cedex 9, and bUniversité de Toulouse, UPS and CNRS, Institut de Chimie de Toulouse, FR2599, 118 route de Narbonne, F-31062 Toulouse cedex 9, France
Correspondence e-mail: benoist@chimie.ups-tlse.fr
In the title compound, C20H29N5O4, the pyridine ring makes a dihedral angle of 10.41 (16)° with the triazole ring, which exhibits an azo-like character. In the crystal, molecules are linked by C-H
O and C-H
N hydrogen bonds, and C-H
interactions involving a methyl group and the pyridine ring of a neighbouring molecule, leading to the formation of a three-dimensional network.
For 4-pyridyl-1,2,3-triazoles as building blocks in the synthesis of chelating agents for biomedical applications, see: Bonnet et al. (2012
); Pellegatti et al. (2008
). For the crystal structures of structural isomers such as 2-pyridyl-1,2,3-triazoles, see: Obata et al. (2008
); Schweinfurth et al. (2008
); Boulay et al. (2010
); Seridi et al. (2011
); Crowley et al. (2010
); Kilpin et al. (2011
).
|
|
|
Data collection: APEX2 (Bruker, 2008
); cell refinement: APEX2 and SAINT (Bruker, 2008
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012
); software used to prepare material for publication: WinGX publication routines (Farrugia, 2012
) and publCIF (Westrip, 2010
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2510 ).
We gratefully acknowledge the French Ministère de l'Education Nationale, de la Recherche et de la Technologie for financial support.
Bonnet, C. S., Buron, F., Caille, F., Shade, C. M., Drahos, B., Pellegatti, L., Zhang, J., Villette, S., Helm, L., Pichon, C., Suzenet, F., Petoud, S. & Toth, E. (2012). Chem. Eur. J. 18, 1419-1431.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Boulay, A., Seridi, A., Zedde, C., Ladeira, S., Picard, C., Maron, L. & Benoist, E. (2010). Eur. J. Inorg. Chem. pp. 5058-5062.
Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Crowley, J. D., Bandeen, P. H. & Hanton, L. R. (2010). Polyhedron, 29, 70-83.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Kilpin, K. J., Gavey, E. L., McAdam, C. J., Anderson, C. B., Lind, S. J., Keep, C. C., Gordon, K. C. & Crowley, J. D. (2011). Inorg. Chem. 50, 6334-6346.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Obata, M., Kitamura, A., Mori, A., Kameyama, C., Czaplewska, J. A., Tanaka, R., Kinoshita, I., Kusumoto, T., Hashimoto, H., Harada, M., Mikata, Y., Funabiki, T. & Yano, S. (2008). Dalton Trans. pp. 3292-3300.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Pellegatti, L., Zhang, J., Drahos, B., Villette, S., Suzenet, F., Guillaumet, G., Petoud, S. & Toth, E. (2008). Chem. Commun. pp. 6591-6593. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Schweinfurth, D., Hardcastle, K. I. & Bunz, U. H. F. (2008). Chem. Commun. pp. 2203-2205.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Seridi, A., Wolff, M., Boulay, A., Saffon, N., Coulais, Y., Picard, C., Machura, B. & Benoist, E. (2011). Inorg. Chem. Commun. 14, 238-242.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.
![[details]](../../../../../../j/graphics/details.gif)